Mannatech (NASDAQ:MTEX) Stock Lifted to “Buy” by Wall Street Zen

Wall Street Zen upgraded shares of Mannatech (NASDAQ:MTEX) to a buy rating in a research note released on Saturday morning,Wall Street Zen reports.

Separately, Weiss Ratings raised shares of Mannatech from a “sell (e+)” rating to a “sell (d-)” rating in a report on Thursday, October 29th. One research analyst has rated the stock with a Sell rating. According to MarketBeat.com, Mannatech currently has an average rating of “Sell”.

Mannatech Price Performance

Shares of MTEX opened at $8.11 on Friday. The business’s fifty day moving average price is $7.87 and its 200 day moving average price is $6.33. Mannatech has a 12-month low of $3.80 and a 12-month high of $9.97. The stock has a market capitalization of $15.65 million, a PE ratio of -2.07 and a beta of 0.62.

Mannatech (NASDAQ:MTEX) last released its earnings results on Wednesday, August 12th. The company reported $0.53 earnings per share for the quarter. The firm had revenue of $26.65 million during the quarter. Mannatech had a negative net margin of 6.90% and a negative return on equity of 2,383.34%.

About Mannatech

Mannatech, Incorporated develops and markets nutritional supplements, health and wellness products, and personal-care products through a direct-selling business model. Its product offerings have included dietary supplements, functional nutrition products, weight-management formulas, and skin-care products, with an emphasis on ingredients intended to support general wellness and healthy aging.

The company is best known for its Ambrotose product line, which incorporates plant-sourced polysaccharides, as well as related nutritional supplements and wellness programs.